Stanley Shaw, MD, PhD

Stanley Shaw is a founding Principal Investigator in the MGH Center for Systems Biology, and an Associate Member of the Broad Institute of Harvard and MIT. His laboratory seeks new ways to phenotype patients and understand disease biology, through a combination of patient-focused studies, functional genomics, chemical biology and bioinformatics (e.g., developing methods to formulate mechanistic and therapeutic hypotheses from both chemical and genetic screening data). He will investigate cardiovascular effects of NSAIDs by interrogating Electronic Medical Records (EMR); in particular, he will evaluate hypotheses drawn from PENTACON studies in model organisms in a large population of human patients.